Wize Pharma

Wize Pharma EBIT Growth

Delisted·Jan 10, 2019

The Year-over-Year EBIT Growth of Wize Pharma (WIZP) as of Nov 19, 2026 is 22.97 %. In the previous year, Year-over-Year EBIT Growth was 12.67 % — a change of 81.23% (higher).

EBIT Growth

22.97 %

YoY

81.23%

Last updated:

Year-over-Year EBIT Growth of Wize Pharma is 2020 22.97 % . Year-over-Year EBIT Growth of Wize Pharma was 2019 12.67 % . It decreases by 81.23% higher compared to the previous year.

The Wize Pharma EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2015
-117.51 USD
Jan 1, 2016
73.24 USD
Jan 1, 2017
-134.71 USD
Jan 1, 2018
-145.10 USD
Jan 1, 2019
12.67 USD
Jan 1, 2020
22.97 USD
The Wize Pharma EBIT Growth history
YEAREBIT GrowthYoY
22.97 %+81.23%
12.67 %-108.73%
-145.10 %+7.72%
-134.71 %-283.93%
73.24 %-162.33%
-117.51 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Year-over-Year EBIT Growth of Wize Pharma is 22.97 % in 2020.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Wize Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Wize Pharma

All Key Metrics — Wize Pharma